Comprehensive genome sequencing of the liver cancer genome

Cancer Lett. 2013 Nov 1;340(2):234-40. doi: 10.1016/j.canlet.2012.10.035. Epub 2012 Nov 8.

Abstract

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death worldwide. Recently, comprehensive whole genome and exome sequencing analyses for HCC revealed new cancer-associated genes and a variety of genomic alterations. In particular, frequent genetic alterations of the chromatin remodeling genes were observed, suggesting a new potential therapeutic target for HCC. Sequencing analysis has further identified the molecular complexities of multicentric lesions and intratumoral heterogeneity. Detailed analyses of the somatic substitution pattern of the cancer genome and the HBV virus genome integration sites by using whole-genome sequencing will elucidate the molecular basis and diverse etiological factors involved in liver cancer development.

Keywords: Chromatin remodeling; HBV integration; Hepatocellular carcinoma; Intratumoral heterogeneity; Multi-centric; Telomerase reverse transcriptase; Whole exome sequencing; Whole genome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Biomarkers, Tumor / genetics*
  • Carcinoma, Hepatocellular / diagnosis
  • Carcinoma, Hepatocellular / genetics*
  • Carcinoma, Hepatocellular / therapy
  • Carcinoma, Hepatocellular / virology
  • Chromatin Assembly and Disassembly / genetics
  • Computational Biology
  • DNA Mutational Analysis
  • Gene Expression Regulation, Neoplastic
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Genome, Human*
  • Genomics / methods*
  • Hepatitis B virus / genetics
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / genetics*
  • Liver Neoplasms / therapy
  • Liver Neoplasms / virology
  • Mutation
  • Phenotype
  • Precision Medicine
  • Predictive Value of Tests
  • Prognosis
  • Sequence Analysis, DNA*

Substances

  • Biomarkers, Tumor